HOXD9 and hepatocellular carcinoma: HOXD9 and BOP1 were both uncovered as the oncogenic promoters of epithelial-mesenchymal transition (EMT) in HCC (Chung et al., 2011; Lv et al., 2015), which was in line with their unfavorable prognostic contribution in our identified prognostic signature.